Top

Indian Journal of Hematology and Blood Transfusion

Published in:

01-06-2016 | Images

Isolated Intravascular Large B-cell Lymphoma Presenting with Diffuse Ground Glass Pulmonary Infiltrates

Authors: Narat Srivali, Bibek S. Pannu, Vivek N. Iyer

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2016

Abstract

A case of 44-year-old man with dyspnea and CT chest demonstrated bilateral infiltration. Patient was failed to improve with antibiotics and steroid. Finally, video-assisted thoracic surgery-guided lung biopsy was performed and surprisingly revealed intravascular large B cell lymphoma. The patient was subsequently started on chemotherapy with considerable clinical improvement. At the time of last follow-up (4 years from diagnosis); there was no clinical or radiologic evidence of tumor recurrence.

Orwat DE, Batalis NI (2012) Intravascular large B-cell lymphoma. Arch Pathol Lab Med 136:333–338CrossRefPubMed

Kotake T, Kosugi S, Takimoto T et al (2010) Intravascular large B-cell lymphoma presenting pulmonary arterial hypertension as an initial manifestation. Intern Med 49:51–54CrossRefPubMed

Ferreri AJ, Campo E, Seymour JF et al (2004) Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’. Br J Haematol 127:173–183CrossRefPubMed

Xiao D, Fu C, Long X et al (2014) Lung intravascular large B-cell lymphoma with ground glass opacities on chest computed tomography: a case report. Int J Clin Exp Pathol 7:5285–5290PubMedPubMedCentral

Srivali N, Prasidthratsint K, Ammannagari N et al (2013) Intravascular large B cell lymphoma presenting as anasarca: an unusual presentation of a rare lymphoma. Ann Hematol 92:275–276CrossRefPubMed

Title: Isolated Intravascular Large B-cell Lymphoma Presenting with Diffuse Ground Glass Pulmonary Infiltrates
Authors: Narat Srivali
Bibek S. Pannu
Vivek N. Iyer
Publication date: 01-06-2016
Publisher: Springer India
Published in: Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-016-0636-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2016

A Case of Chronic Lymphocytic Leukaemia Occurring During Treatment of Chronic Myeloid Leukaemia

Obstructive Uropathy as an Initial Presentation of Primary Myelofibrosis: Case Report and Review of Literature

Avascular Necrosis of Head of Femur in Dyskeratosis Congenita - A Rare Presentation

Concomitant Presence of Two Distinct Clones of Chronic Lymphocytic Leukemia and Plasma Cell Myeloma in a Patient

Anemia and Thrombocytopenia in New H5N6 Influenza: Existed or not?

Bilateral Tonsillar Enlargement as a First Manifestation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with an Unusual Interfollicular Pattern of Infiltration

Keynote webinar | Spotlight on antibody–drug conjugates in cancer